Healthy volunteers help test new drug combo for future infections
NCT ID NCT06079775
First seen Nov 03, 2025 · Last updated Jun 13, 2026 · Updated 30 times
Summary
This early-stage study tested a new oral drug (QPX7831) combined with an antibiotic (ceftibuten) in 53 healthy adults aged 18-55. The goal was to check safety and how the drugs interact in the body, not to treat any disease. Results will help design future studies for bacterial infections.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BACTERIAL INFECTIONS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CMAX
Adelaide, South Australia, 5000, Australia
Conditions
Explore the condition pages connected to this study.